31/07/2024 |
6-K |
Notice and Proxy Statement for the Special General Meeting |
|
29/07/2024 |
6-K |
SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine |
|
25/07/2024 |
20-F/A |
Amendment No. 1 on Form 20-F/A – Annual Report |
|
20/06/2024 |
6-K |
SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity |
|
09/05/2024 |
6-K |
SHL announces Special General Meeting Results |
|
18/04/2024 |
20-F |
Form 20-F |
|
17/04/2024 |
6-K |
SHL Telemedicine Ltd Announces the filing of Full-Year 2023 Results |
|
26/03/2024 |
6-K |
Notice and Proxy Statement for the Special General Meeting |
|
14/03/2024 |
6-K |
SHL announces change in CEO position |
|